Literature DB >> 22826208

Individual and family characteristics associated with BRCA1/2 genetic testing in high-risk families.

Maria C Katapodi1, Laurel L Northouse, Kara J Milliron, Guipeng Liu, Sofia D Merajver.   

Abstract

BACKGROUND: Little is known about family members' interrelated decisions to seek genetic testing for breast cancer susceptibility.
METHODS: The specific aims of this cross-sectional, descriptive, cohort study were (i) to examine whether individual and family characteristics have a direct effect on women's decisions to use genetic testing for hereditary susceptibility to breast cancer and (ii) to explore whether family characteristics moderate the relationships between individual characteristics and the decision to use genetic testing. Participants were women (>18 years old) who (i) received genetic testing for hereditary breast cancer and who agreed to invite one of their female relatives into the study and (ii) female relatives who had NOT obtained genetic testing and were identified by pedigree analysis as having >10% chances of hereditary susceptibility to breast cancer.
RESULTS: The final sample consisted of 168 English-speaking, family dyads who completed self-administered, mailed surveys with validated instruments. Multivariate conditional logistic regression analyses showed that the proposed model explained 62% of the variance in genetic testing. The factors most significantly associated with genetic testing were having a personal history of cancer; perceiving genetic testing to have more benefits than barriers; having greater family hardiness; and perceiving fewer negative consequences associated with a breast cancer diagnosis. No significant interaction effects were observed.
CONCLUSIONS: Findings suggest that both individual and family characteristics are associated with the decision to obtain genetic testing for hereditary breast cancer; hence, there is a need for interventions that foster a supportive family environment for patients and their high-risk relatives.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22826208     DOI: 10.1002/pon.3139

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  11 in total

1.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

Review 2.  Targeting the therapeutic effects of exercise on redox-sensitive mechanisms in the vascular endothelium during tumor progression.

Authors:  Gretchen Wolff; Michal Toborek
Journal:  IUBMB Life       Date:  2013-06-12       Impact factor: 3.885

3.  Sharing genetic test results with family members of BRCA, PALB2, CHEK2, and ATM carriers.

Authors:  Marleah Dean; Ann L Tezak; Sabrina Johnson; Joy K Pierce; Anne Weidner; Kate Clouse; Tuya Pal; Deborah Cragun
Journal:  Patient Educ Couns       Date:  2021-01-05

4.  Cancer Predisposition Cascade Screening for Hereditary Breast/Ovarian Cancer and Lynch Syndromes in Switzerland: Study Protocol.

Authors:  Maria C Katapodi; Valeria Viassolo; Maria Caiata-Zufferey; Christos Nikolaidis; Nicole Buerki; Karl Heinimann; Viola Heinzelmann-Schwarz; Olivia Pagani; Pierre O Chappuis; Rosmarie Bührer-Landolt; Rossella Graffeo; Henrik Csaba Horváth; Christian Kurzeder; Manuela Rabaglio; Michael Scharfe; Corinne Urech; Tobias E Erlanger; Nicole Probst-Hensch
Journal:  JMIR Res Protoc       Date:  2017-09-20

5.  Development of a Web-based Family Intervention for BRCA Carriers and Their Biological Relatives: Acceptability, Feasibility, and Usability Study.

Authors:  Maria C Katapodi; Miyeon Jung; Ann M Schafenacker; Kara J Milliron; Kari E Mendelsohn-Victor; Sofia D Merajver; Laurel L Northouse
Journal:  JMIR Cancer       Date:  2018-04-13

6.  Residential Locale Is Associated with Disparities in Genetic Testing-Related Outcomes Among BRCA1/2-Positive Women.

Authors:  Kate E Dibble; Avonne E Connor
Journal:  J Racial Ethn Health Disparities       Date:  2022-02-17

7.  Psychosocial impact of prognostic genetic testing in the care of uveal melanoma patients: protocol of a controlled prospective clinical observational study.

Authors:  Yesim Erim; Jennifer Scheel; Anja Breidenstein; Claudia Hd Metz; Dietmar Lohmann; Hans-Christoph Friederich; Sefik Tagay
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

8.  Predictors and interdependence of family support in a random sample of long-term young breast cancer survivors and their biological relatives.

Authors:  Maria C Katapodi; Katrina R Ellis; Franziska Schmidt; Christos Nikolaidis; Laurel L Northouse
Journal:  Cancer Med       Date:  2018-09-05       Impact factor: 4.452

9.  Prevalence of germline mutations in the TP53 gene in patients with early-onset breast cancer in the Mexican population.

Authors:  Lenny N Gallardo-Alvarado; María Teresa Tusié-Luna; María Isabel Tussié-Luna; José Díaz-Chávez; Yayoi X Segura; Enrique Bargallo-Rocha; Cynthia Villarreal; Luis A Herrera-Montalvo; Enrique M Herrera-Medina; David F Cantu-de Leon
Journal:  BMC Cancer       Date:  2019-02-01       Impact factor: 4.430

10.  Genetic Literacy and Communication of Genetic Information in Families Concerned with Hereditary Breast and Ovarian Cancer: A Cross-Study Comparison in Two Countries and within a Timeframe of More Than 10 Years.

Authors:  Carla Pedrazzani; Chang Ming; Nicole Bürki; Maria Caiata-Zufferey; Pierre O Chappuis; Debra Duquette; Karl Heinimann; Viola Heinzelmann-Schwarz; Rossella Graffeo-Galbiati; Sofia D Merajver; Kara J Milliron; Christian Monnerat; Olivia Pagani; Manuela Rabaglio; Maria C Katapodi
Journal:  Cancers (Basel)       Date:  2021-12-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.